The profile of the 263 significant differentially expressed metabolites (DEMs). by Haiying Yang (11707725)

Subjects:

Significant differences in monthly mean precipitation [mm/mon] between 7ka BP and PI, simulated by MPI-ESM. by Fabian Kirsten (17310195)

Significant differences in monthly mean soil moisture between 7ka BP and PI [mm], simulated by MPI-ESM. by Fabian Kirsten (17310195)

Flow diagram of the study. by Yoonjee Cho (15453454)

“…Based on the AUT, the patients were divided into a high-decrease group (n = 156) and a low-decrease group (n = 240). …”

Baseline characteristics of patients. by Yoonjee Cho (15453454)

“…Based on the AUT, the patients were divided into a high-decrease group (n = 156) and a low-decrease group (n = 240). …”

Data_Sheet_1_Pulmonary Exposure to Magnéli Phase Titanium Suboxides Results in Significant Macrophage Abnormalities and Decreased Lung Function.PDF by Dylan K. McDaniel (8054981)

CLDT Metabolomics Table S3. Significant changes in metabolites from pre- to post-CLDT by Meaghan Beckner (11436547)

“…<p>Supplemental Table 3. Significant changes in the serum metabolome during Cadet Leader Development Training (CLDT). …”

Summary of significantly up-regulated protein-coding genes in each tissue. by Marie Morin (15240596)

Case of normal load changing. by Basem Abd-Elhamed Rashad (17781467)

The fluorescence of FAM-myristoyl-H4K16 peptide does not significantly change when bound to SIRT2 alone. by Jie Yang (121778)

Volcano Map, Heatmap of DEGs, and Shared Gene Identification:(A) Volcano map: Significant gene expression changes in GSE73680. by Zhikai Su (21144119)

Expected changes in facial shape due to breastfeeding based on our PSLR model. by Seppe Goovaerts (19688352)

Changes in firms’ ratings while and following COVID-19 based on TOPSIS. by Chia-Nan Wang (17518818)

Changes in firms’ ratings while and following COVID-19 based on EDAS. by Chia-Nan Wang (17518818)

S8 File - by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”

Study populations of included studies. by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”

Future research directions. by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”

PRISMA flow diagram. by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”

S9 File - by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”

S7 File - by Martha R. Smith (20410184)

“…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”